Forest Laboratories was a US-based pharmaceutical and biotechnology company. It was acquired by Actavis.
Forest Laboratories develops, manufactures, and markets medicines to the patients who are suffering from diseases in the central nervous system, women's health, gastroenterology,urology, cardiovascular, respiratory, and anti-infective therapeutic categories.
The company's products include Bystolic, which is used to lower heart rate and myocardial contractility; Daliresp, which is used to lower the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treating irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treating moderate to severe dementia.
The company was acquired by Actavis.
Now, Allergan is a company developing, manufacturing and marketing branded forms of ethical drug products
Forest Laboratories was a US-based pharmaceutical and biotechnology company. It was acquired by Actavis.
Forest Laboratories is a company that operates as a pharmaceutical company. Forest Laboratories develops, manufactures, and markets medicines to the patients who are suffering from diseases in the central nervous system, women's health, gastroenterology,urology, cardiovascular, respiratory, and anti-infective therapeutic categories.
The company was acquired by Actavis.
The company's products include Bystolic, which is used to lower heart rate and myocardial contractility; Daliresp, which is used to lower the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treating irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treating moderate to severe dementia.
Forest Laboratories is a company that operates as a pharmaceutical company. Forest Laboratories develops, manufactures, and markets medicines to the patients who are suffering from diseases in the central nervous system, women's health, gastroenterology,urology, cardiovascular, respiratory, and anti-infective therapeutic categories.
The products include Bystolic, which is used to lower heart rate and myocardial contractility; Daliresp, which is used to lower the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treating irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treating moderate to severe dementia.